quinapril has been researched along with Diabetes Mellitus, Type 1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emmett, T; Kargacin, G; Nygren, A; Schmidt, R; Shimoni, Y | 1 |
| Liu, XF; Shimoni, Y | 1 |
| Barrett, P; Connell, J; Glenn, A; Kesson, CM; McKenna, K; Smith, D; Thompson, CJ | 1 |
| Donker, AJ; Lambert, J; Schalkwijk, CG; Smulders, RA; Stehouwer, CD | 1 |
| Shimoni, Y | 1 |
| Brocco, E; Carraro, A; Cipollina, MR; Fioretto, P; Giorato, C; Mantero, F; Morocutti, A; Opocher, G; Sacerdoti, D; Sambataro, M | 1 |
2 trial(s) available for quinapril and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Creatinine; Diabetes Mellitus, Type 1; Humans; Insulin; Isoquinolines; Kinetics; Male; Placebos; Quinapril; Tetrahydroisoquinolines | 2000 |
ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Double-Blind Method; E-Selectin; Endothelins; Endothelium, Vascular; Female; Humans; Isoquinolines; Male; Plasminogen Activator Inhibitor 1; Quinapril; Tetrahydroisoquinolines; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1; Vasodilation; von Willebrand Factor | 2000 |
5 other study(ies) available for quinapril and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Sex-dependent impairment of cardiac action potential conduction in type 1 diabetic rats.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Connexin 43; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Gap Junctions; Heart Conduction System; Heptanol; Male; Ovariectomy; Quinapril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sex Factors; Tetrahydroisoquinolines; Time Factors | 2009 |
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
Topics: Adolescent; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Atorvastatin; Biomarkers; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multicenter Studies as Topic; Puberty; Pyrroles; Quinapril; Randomized Controlled Trials as Topic; Research Design; Risk; Tetrahydroisoquinolines | 2009 |
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides | 2004 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |
Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Diabetes Mellitus, Type 1; Glomerular Filtration Rate; Humans; Isoquinolines; Male; Middle Aged; Natriuresis; Quinapril; Sodium; Tetrahydroisoquinolines | 1992 |